Can-Fite BioPharma Files Form 6-K
Ticker: CANF · Form: 6-K · Filed: May 16, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: CANF
TL;DR
Can-Fite BioPharma filed a 6-K on May 16, 2025, incorporating it into existing SEC filings.
AI Summary
On May 16, 2025, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating this report into its existing Registration Statements on Form S-8 and Form F-3. The filing pertains to the month of May 2025 and is for a foreign private issuer.
Why It Matters
This filing updates the SEC with information relevant to Can-Fite BioPharma Ltd. as a foreign private issuer, potentially impacting investors' understanding of the company's ongoing disclosures.
Risk Assessment
Risk Level: low — This filing is a routine disclosure report and does not appear to contain significant new financial or operational information that would immediately alter risk.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer of the Form 6-K
- May 16, 2025 (date) — Date of filing and report
- Form 6-K (document) — Type of SEC filing
- Form S-8 (document) — Registration statement into which 6-K is incorporated
- Form F-3 (document) — Registration statement into which 6-K is incorporated
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer would be required to make public pursuant to the laws of its home country, or that it may otherwise make or be required to make public.
When was this specific Form 6-K filed?
This Form 6-K was filed on May 16, 2025.
Which registration statements does this 6-K filing get incorporated into?
This Form 6-K is incorporated by reference into Can-Fite BioPharma Ltd.'s Registration Statements on Form S-8 (File No. 333-227753, 333-271384 and 333-278525) and Form F-3 (File Nos. 333-236064, 333-276000, 333-274316, 333-281872, and 333-262055).
What is Can-Fite BioPharma Ltd.'s principal executive office address?
Can-Fite BioPharma Ltd.'s principal executive offices are located at 26 Ben Gurion Street, Ramat Gan 5257346, Israel.
Is Can-Fite BioPharma Ltd. required to file annual reports on Form 20-F or Form 40-F?
Yes, Can-Fite BioPharma Ltd. indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 16, 2025 regarding Can-Fite BioPharma Ltd. (CANF).